NYSEARCA:HRTS Tema Obesity & Cardiometabolic ETF (HRTS) Price, Holdings, & News $27.69 +0.28 (+1.02%) As of 04/17/2025 03:30 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsBuy This Stock About Tema Obesity & Cardiometabolic ETF (NYSEARCA:HRTS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HRTS alerts:Sign Up Key Stats Today's Range$27.39▼$27.6950-Day Range$26.25▼$30.8152-Week Range$25.32▼$36.03Volume4,703 shsAverage Volume12,579 shsMarket Capitalization$53.72 millionAssets Under Management$524,000.00Dividend Yield1.70%Net Expense Ratio0.00%Aggregate RatingModerate Buy ETF OverviewThe Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.Read More… Tema Obesity & Cardiometabolic ETF ExpensesTypeHRTSNYSEARCA ETFsAll ETFsManagement Fee0.00%0.52%0.53%Other Expenses0.00%0.56%0.52%Total Expense0.00%0.73%0.71%Fee Waiver0.00%-0.66%-0.55%Net Expense0.00%0.58%0.60% Receive HRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tema Obesity & Cardiometabolic ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address HRTS ETF News HeadlinesHRTS Tema Obesity & Cardiometabolic ETFApril 10, 2025 | seekingalpha.comEli Lilly’s quest for obesity drugs leads to $1B bet on dark genomeSeptember 6, 2024 | seekingalpha.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 20, 2025 | Porter & Company (Ad)HRTS: Generating Alpha In Obesity TreatmentJuly 25, 2024 | seekingalpha.comHRTS: Exposure To GLP-1 Drug Developers Means Plenty Of UpsideJuly 19, 2024 | seekingalpha.comWeight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up SupplyMay 29, 2024 | msn.comSee More Headlines HRTS ETF - Frequently Asked Questions How have HRTS shares performed this year? Tema Obesity & Cardiometabolic ETF's stock was trading at $28.87 at the beginning of 2025. Since then, HRTS stock has decreased by 4.1% and is now trading at $27.69. View the best growth stocks for 2025 here. How do I buy shares of Tema Obesity & Cardiometabolic ETF? Shares of HRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tema Obesity & Cardiometabolic ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Obesity & Cardiometabolic ETF investors own include Intuitive Surgical (ISRG), Adobe (ADBE), Accenture (ACN), Alpha Metallurgical Resources (AMR), Arista Networks (ANET), AppLovin (APP) and Arch Biopartners (ARCH). Fund Details Issuer Fund NameTema Cardiovascular and Metabolics ETF Tax Classification Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:HRTS Inception Date1/1/2100 Fund ManagerN/A WebN/A PhoneN/AFund Focus Asset Class BenchmarkN/A Category Focus Development Level Region Number of Holdings40 Fund Statistics Assets Under Management$524,000.00 Average Daily Volume$0.00 Discount/Premium0.43% Administrator, Advisor and Custodian AdministratorN/A AdvisorN/A CustodianN/A DistributorN/A Transfer AgentN/A TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares1,940,000Beta0.93 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report Top 10 HRTS HoldingsEli Lilly and Company (NYSE:LLY)Holding Weight: 9.94%UnitedHealth Group (NYSE:UNH)Holding Weight: 7.17%AstraZeneca PLCHolding Weight: 4.18%Novo Nordisk A/SHolding Weight: 4.08%BridgeBio Pharma (NASDAQ:BBIO)Holding Weight: 4.03%Abbott Laboratories (NYSE:ABT)Holding Weight: 4.01%Roche (OTCMKTS:RHHBY)Holding Weight: 3.74%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 3.65%Gilead Sciences (NASDAQ:GILD)Holding Weight: 3.20%Medtronic (NYSE:MDT)Holding Weight: 3.10%Full Holdings DetailsHRTS Sector ExposureHRTS Industry Exposure This page (NYSEARCA:HRTS) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Obesity & Cardiometabolic ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Obesity & Cardiometabolic ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
